Last updated: January 26, 2021
Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Overall Status: Completed
Phase
N/A
Condition
High Blood Pressure (Hypertension)
Stress
Vascular Diseases
Treatment
N/AClinical Study ID
NCT04564118
909-2020
Ages > 19 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age > 18 years old
- Patients diagnosed with nonvalvular atrial fibrillation and essential hypertensionhaving indications for therapy according to European guidelines.
Exclusion
Exclusion Criteria:
- Valvular cause of atrial fibrillation
- GFR less than 30 ml / min
- Active liver disease
- Acute coronary syndrome
- The presence of thyroid diseases as a cause of atrial fibrillation
- Secondary arterial hypertension
Study Design
Total Participants: 191
Study Start date:
September 01, 2020
Estimated Completion Date:
January 11, 2021
Study Description
Connect with a study center
V.A. Almazov Fnmrc
Saint-petersburg, 197341
Russian FederationSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.